Immune Checkpoint Inhibitors for Child-Pugh B Hepatocellular Carcinoma

Дата публикации: 01-10-2023 00:00:00

This systematic review and meta-analysis evaluates the efficacy and safety of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with Child-Pugh class B liver function.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer	0	7.64	01-10-2024
2	Cardiotoxicity of Immune Checkpoint Inhibitors	0	8	01-10-2024
3	Checkpoint Inhibitors Plus Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors	0	4.57	01-09-2023
4	Antiangiogenic Class and Trial Population Are Confounded in First- Line Immunotherapy for Hepatocellular Carcinoma: A Bayesian Network Meta-Analysis of Nine Randomised Trials	0	17.14	21-10-2026
5	Multimodal model for diagnosis of tumor-associated macrophages with M2 polarization and prognosis of targeted therapy in hepatocellular carcinoma: A multicenter retrospective study	0	16.19	10-08-2026
6	PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression	0	15.58	01-07-2026
7	Contemporary Management of Acute Myeloid Leukemia	0	10.41	01-10-2024
8	Common cholesterol drug may improve the effectiveness of immunotherapy in liver cancer patients	0	6.12	21-09-2026
9	CAR T Cells and T-Cell Therapies for Cancer	0	12.98	10-12-2024
10	Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma	0	5.96	30-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.22. Источник: archderm.jamanetwork.com.